RT Journal Article
SR Electronic
T1 Assessment of respiratory droplet transmission during the ophthalmic slit lamp exam: a particle tracking analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.25.20140335
DO 10.1101/2020.06.25.20140335
A1 Shah, Sahil H.
A1 Garg, Anupam K.
A1 Patel, Shiv
A1 Yim, Wonjun
A1 Jokerst, Jesse
A1 Chao, Daniel L.
YR 2020
UL http://medrxiv.org/content/early/2020/06/26/2020.06.25.20140335.abstract
AB Importance The global COVID-19 pandemic, which began in late 2019, has resulted in a renewed focus on the importance of personal protective equipment (PPE) and other interventions to decrease the spread of infectious diseases. While several ophthalmology organizations have recently released guidance on appropriate PPE for surgical procedures and ophthalmology clinics, there is limited experimental evidence demonstrating the efficacy of the various interventions that have been suggested. In this study, we evaluate high-risk aspects of the slit-lamp exam and the effect of various PPE interventions.Objective To determine the effectiveness of surgical masks, slit lamp shields, and gloves in decreasing the spread of large droplets in an ophthalmology clinical setting and evaluating high-risk sources of contamination.Design Experimental cough simulation using a fluorescent surrogate of respiratory droplets during an ophthalmic slit lamp examination.Setting Single-centerParticipants Patient SimulationMain outcomes and measure(s) Presence of fluorescent particles in the air near or on slit lamp and simulated slit lamp examiner.Results Simulated coughing without a mask or slit lamp shield resulted in widespread dispersion of fluorescent droplets on the model slit lamp examination. Coughing with a mask resulted in the most significant decrease in fluorescent droplets, however, particles were still seen to escape from the top of the mask. Coughing with the slit lamp shield alone blocked the majority of forward particle dispersion; however significant distributions of respiratory droplets were found on the slit lamp joystick as well as table. Coughing with both mask and slit lamp shield resulted in the least dispersion on to the simulated examiner. Scanning electron microscopy demonstrated particle sizes of 3-100μm.Conclusion and relevance Masking has the greatest effect in limiting spread of respiratory droplets, while slit lamp shields, and gloves also contribute to limiting exposure to respiratory droplets from SARS-CoV-2 during slit lamp examination.Question How effective are certain personal protective equipment and interventions in the clinic in preventing respiratory droplet spread?Findings Simulating patient coughing during the slit lamp exam demonstrated that masking appeared to be the most effective intervention to prevent spread of respiratory droplets. Slit lamp shields and gloves were also effective in decreasing exposure to respiratory droplets.Meaning This study confirms the importance of masking, slit lamp shields, as well as gloves as important interventions to limit exposure to respiratory droplets from respiratory viruses such as SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementD.L.C. was funded by NIH/NEI K08EY030510 and an unrestricted department grant for Research to Prevent Blindness. J.J. was funded by University of California Tobacco Related-Disease Research Program (TRDRP) under Emergency COVID-19 Research Seed Funding award number R00RG2515, the NIH under grants DP2 HL137187 and R21 AG065776, and the NSF under grant #1845683.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available upon reasonable request.